Group 1 - The core point of the announcement is that Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. has received a notification from its controlling shareholder, Heilongjiang Chuangda Group Co., Ltd., regarding the adjustment of the conversion price for the first phase of the non-public issuance of exchangeable bonds [1][2] - The first phase of the exchangeable bonds, referred to as "23 Chuang01EB," was issued on April 11, 2023, with a total scale of 910 million yuan and a term of three years [1] - The conversion price for the exchangeable bonds will be automatically adjusted from 7.75 yuan per share to 7.30 yuan per share due to the stock price falling below 10 yuan per share for at least 10 trading days within a 30-day period [2] Group 2 - The adjusted conversion price will take effect on March 2, 2026, and the number of shares prepared for exchange in the pledge account of the exchangeable bonds will still meet the requirements for full conversion [2] - The company will closely monitor the progress of the exchangeable bonds and fulfill its continuous information disclosure obligations as required [2]

Group 1 - The core point of the announcement is the adjustment of the conversion price for the exchangeable bonds issued by the controlling shareholder, Heilongjiang Chuangda Group, to protect the interests of bondholders [1][2] - The first phase of the exchangeable bonds, named "23 Chuang 01 EB," was issued on April 11, 2023, with a total scale of 910 million yuan and a maturity of three years [1] - The conversion price has been revised from 13.35 yuan per share to 12.35 yuan per share, effective from August 27, 2025, following the approval of the bondholders [2] Group 2 - The adjustment of the conversion price is based on the average closing price of the company's stock over the 20 trading days prior to the board resolution and the closing price on the day before the resolution [2] - The number of shares pledged for the exchangeable bonds will still meet the total required for the conversion after the price adjustment [2] - The company will continue to monitor the progress of the exchangeable bonds and fulfill its ongoing information disclosure obligations [2]

Group 1 - The company announced a price adjustment for the exchangeable bonds issued by its controlling shareholder, Heilongjiang Chuangda Group Co., Ltd. [1][2] - The first phase of the exchangeable bonds, with a total issuance of 910 million yuan and a term of 3 years, was completed on April 11, 2023 [1] - The second phase of the exchangeable bonds, with a total issuance of 90 million yuan and a term of 3 years, was completed on June 28, 2023 [2] Group 2 - The company’s 2024 profit distribution plan includes a cash dividend of 1.50 yuan per 10 shares, totaling approximately 141.13 million yuan [3] - The adjusted cash dividend per share, after considering the total share capital dilution, will be 0.15 yuan per share [3] - The record date for the profit distribution is set for August 19, 2025, with the ex-dividend date and cash dividend payment date on August 20, 2025 [3] Group 3 - The adjustment of the exchange price for the bonds is based on the company's profit distribution and follows specific formulas outlined in the bond issuance prospectus [4][5] - The exchange price for the first phase bond will be adjusted from 13.50 yuan to 13.35 yuan per share, while the second phase bond will be adjusted from 10.69 yuan to 10.54 yuan per share [5] - The controlling shareholder has sufficient stock available for the exchange after the price adjustments [5]